Variables | Category | CKD status | Crude HR [95% CI] | Adjusted HR [95% CI] | |
---|---|---|---|---|---|
Censored | Event | ||||
Sex | Male | 185 | 30 | 1 | |
Female | 188 | 32 | 0.94 (0.57, 1.54) | ||
Age | 1.07 (1.04, 1.09) | 1.06 (1.03, 1.09)* | |||
Diabetic retinopathy | Yes | 357 | 47 | 1 | 1 |
No | 16 | 15 | 0.11 (0.06, 0.2) | 0.13 (0.07, 0.24)* | |
History of hypertension | No | 174 | 26 | 1 | |
Yes | 199 | 36 | 1.18 (0.71, 1.95) | ||
Hypertensive therapy | No | 213 | 38 | 1 | |
Yes | 160 | 24 | 0.83 (0.5, 1.4) | ||
Types of DM therapy | Insulin | 85 | 16 | 1 | |
Oral | 288 | 46 | 0.96 (0.54, 1.7) | ||
FBG(mg/dl) | 0.99 (0.995, 1.002) | ||||
SBP (mmHg) | 1.02 (1.01, 1.03) | ||||
DBP (mmHg) | 1.03 (1.01, 1.05) | ||||
LDL cholesterol | < 100 mg/dl | 221 | 40 | 1 | |
≥ 100 mg/dl | 113 | 22 | 1.02 (0.61, 1.72) | ||
HDL cholesterol | < 40 mg/dl | 155 | 45 | 1 | 1 |
≥ 40 mg/dl | 179 | 17 | 0.35 (0.2, 0.62) | 0.55 (0.31, 0.97)* | |
Total cholesterol | < 200 mg/dl | 221 | 38 | 1 | |
≥ 200 mg/dl | 118 | 24 | 1.09 (0.65, 1.8) | ||
Triglyceride | < 150 mg/dl | 221 | 38 | 1 | |
≥ 150 mg/dl | 118 | 24 | 1.35 (0.81, 2.25) | ||
BMI (kg/m2) | 1.2 (1.1, 1.3)* | 1.17 (1.1, 1.25)* | |||
LR test χ2(6) = 96.7, P > χ2 = 0.0000, Log likelihood = − 113.6 | AIC = 243.2 |